Institute of Biochemistry I/ZAFES, Faculty of Medicine, Goethe-University Frankfurt, Germany.
Anticancer Agents Med Chem. 2011 Nov;11(9):818-29. doi: 10.2174/187152011797655096.
The sphingolipid sphingosine-1-phosphate (S1P) is an important regulator of immune cell functions in vivo. Besides recruiting lymphocytes to blood and lymph, it may promote immune cell survival and proliferation, but also interferes with their activation. Hereby, S1P may act as an intracellular second messenger or cofactor or, upon being secreted from cells, may bind to and activate a family of specific G-protein-coupled receptors (S1PR1-5). Extracellular versus intracellular S1P hereby might trigger synergistic/identical or fundamentally distinct responses. Furthermore, engagement of different S1PRs is connected to different functional outcome. This complexity is exemplified by the influence of S1P on the inflammatory potential of macrophages, shaping their role in inflammatory pathologies such as atherosclerosis and cancer. Here, we summarize the recent progress in understanding the impact of S1P signaling in macrophage biology, discuss its impact in solid as well as 'wet' tumors and elaborate potential options to interfere with S1P signaling in the context of cancer.
鞘氨醇-1-磷酸(S1P)是体内免疫细胞功能的重要调节剂。除了将淋巴细胞募集到血液和淋巴中,它还可能促进免疫细胞的存活和增殖,但也会干扰其激活。因此,S1P 可以作为细胞内的第二信使或辅助因子,或者在从细胞中分泌后,与特定的 G 蛋白偶联受体家族(S1PR1-5)结合并激活它们。细胞外与细胞内的 S1P 可能引发协同/相同或根本不同的反应。此外,不同 S1PR 的参与与不同的功能结果相关。S1P 对巨噬细胞炎症潜能的影响就是这种复杂性的一个例子,它塑造了它们在动脉粥样硬化和癌症等炎症性疾病中的作用。在这里,我们总结了理解 S1P 信号在巨噬细胞生物学中作用的最新进展,讨论了它在实体瘤和“湿”瘤中的影响,并详细阐述了在癌症背景下干扰 S1P 信号的潜在选择。